Prolonged apnoea following suxamethonium in a staphylococcal toxic shock syndrome;APNEE PROLONGEE APRES ADMINISTRATION SUXAMETHONIUM AU COURS D'UN CHOC TOXIQUE STAPHYLOCOCCIQUE

Annales Francaises d'Anesthesie et de Reanimation

Volumn 15, Issue 2, 1996, Pages 189-191

  Blanloeil Y ^b   Delaroche, O ^a   Tequi, B ^b   Gunst, J P ^b   Dixneuf, B ^b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

apnoea; prolonged curarisation; pseudocholinesterase deficiency; suxamethonium; toxic shock syndrome

Indexed keywords

CHOLINESTERASE; SUXAMETHONIUM; SUXAMETHONIUM IODIDE; NEUROMUSCULAR DEPOLARIZING AGENT;

ADULT; APNEA; ARTICLE; CASE REPORT; DRUG SAFETY; HUMAN; LIVER FAILURE; MALE; ORTHOPEDIC SURGERY; STAPHYLOCOCCUS; TOXIC SHOCK SYNDROME; BLOOD; CHEMICALLY INDUCED DISORDER; METABOLISM; SEPTIC SHOCK; STAPHYLOCOCCUS INFECTION;

ADULT; APNEA; CHOLINESTERASES; HUMANS; MALE; NEUROMUSCULAR DEPOLARIZING AGENTS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; SUCCINYLCHOLINE;

EID: 0343183020     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/0750-7658(96)85041-6     Document Type: Article

References (13)

1. Allderdice PW, Gardner HAR, Galutira D, Lockridge O, Ladu BN, McAlpine PJ. The clone butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26. Genomics 1991;11:452-4
2. Jensen FS, Viby-Mogensen J. Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years'experience with the Danish Cholinesterase research unit. Acta Anaesthesiol Scand 1995;39:150-6
3. Whittaker M. Plasma cholinesterase variants and the anaesthetist. Anaesthesia 1980;35:174-97
4. Viby-Mogensen J, Hanel HK. Prolonged apnoea after suxamethonium. Acta Anaesthesiol Scand 1978;22:371-80
5. Viby-Mogensen J. Succinylcholine neuromuscular blockade in subjects homozygous for atypical plasma cholinesterase. Anesthesiology 1981;55:429-34
6. Knedel LM, Bottger R. Eine kinetische Methode zur Bestimmung der Aktivität der Pseudocholinesterase. Klin Wochenschr 1967;45:325-7
7. Kalow W, Genest K. A method for the detection of atypical forms of human serum cholinesterase: determination of dibucaine numbers. Can J Biochem Physiol 1957;35:339-46
8. Harris H, Whittaker M. Differential inhibition of human serum cholinesterase with fluoride: recognition of two new phenotypes. Nature 1961;191:496-8
9. Savarese JJ, Ali HH, Murphy JD, Padget C, Lee CM, Ponitz J. Train of four stimulation in the management of prolonged neuromuscular blockade following succinylcholine. Anesthesiology 1975;42:106-11
10. Hall GM, Wood GJ, Paterson JL. Half-life of plasma cholinesterase. Br J Anaesth 1984;56:903-4
11. Larkin SM, Williams DN, Osterholm MT, Tofte RW, Posalaky Z. Toxic-shock syndrome: clinical laboratory and pathologic findings in nine fatal cases. Ann Intern Med 1982;96:858-64
12. Oropollo AT. Abnormal pseudocholinesterase levels in a surgical population. Anesthesiology 1978;48:284-6
13. Devlin JC, Head-Rapson AG, Parker CJR, Hunter JM. Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. Br J Anaesth 1993;71:227-31